Dr. Robert Zeldin RE: Separation Agreement and General Release Dear Robert,Separation Agreement and General Release • April 8th, 2020 • Immunovant, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 8th, 2020 Company Industry JurisdictionYour employment with Immunovant, Inc. and any of its subsidiaries will be terminated on April 7, 2020 (the “Separation Date”). This Separation Agreement and General Release (this “Agreement”) sets forth the terms and conditions under which the Company is offering you additional pay and benefits in exchange for you making and honoring certain commitments, including agreeing not to pursue legal action against the Company as described in Sections 7 and 8 of this Agreement.